US equities
|
SPCX
$163.62
▲+10.71%
MU
$912.42
▲+1.83%
TSLA
$385.92
▲+3.27%
NVDA
$220.49
▲+1.85%
SNDK
$1,381.01
▲+1.14%
META
$711.94
▲+2.55%
GOOGL
$333.65
▼-1.95%
AAPL
$344.76
▲+1.55%
SPCX
$163.62
▲+10.71%
MU
$912.42
▲+1.83%
TSLA
$385.92
▲+3.27%
NVDA
$220.49
▲+1.85%
SNDK
$1,381.01
▲+1.14%
META
$711.94
▲+2.55%
GOOGL
$333.65
▼-1.95%
AAPL
$344.76
▲+1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Clinical Study Results
Recent news which mentions Clinical Study Results
Apellis Shares Show Mixed Reaction After Positive 2 Years Data From Late-Stage Retinal Disorder Study
August 24, 2022
Tickers
APLS
Tags
Market News
Health Care
Biotech
From
Benzinga
UNITY Biotechnology Shares Rally After Positive Results From Mid-Stage Age-related Eye Disease Study
August 12, 2022
Tickers
UBX
Tags
UBX
Market News
Penny Stocks
From
Benzinga
VYNE Therapeutics Shares Plummet As Mid-Stage Skin Disease Study Missed Primary Endpoint
August 10, 2022
Tickers
VYNE
Tags
General
Movers & Shakers
Clinical Study Results
From
Benzinga